UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Journal of clinical oncology, 2015-01, Vol.33 (1), p.13-21

2015

Volltextzugriff (PDF)

PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim

Breast cancer research : BCR, 2020-06, Vol.22 (1), p.1-72, Article 72

2020

Volltextzugriff (PDF)

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

Nature communications, 2021-08, Vol.12 (1), p.4671-4671, Article 4671

2021

Volltextzugriff (PDF)

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Nature, 2005-12, Vol.438 (7069), p.820-827

2005

Volltextzugriff (PDF)

Lymphedema Precautions: Time to Abandon Old Practices?

Journal of clinical oncology, 2016-03, Vol.34 (7), p.655-658

2016

Volltextzugriff (PDF)

Surgery No More? Managing the Primary Tumor in Stage IV Breast Cancer

Journal of clinical oncology, 2022-03, Vol.40 (9), p.927-931

2022

Volltextzugriff (PDF)

HER-2/neu status is a determinant of mammary aromatase activity in vivo : Evidence for a cyclooxygenase-2-dependent mechanism

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5504-5511

2006

Volltextzugriff (PDF)

Genetic Testing in Patients With Newly Diagnosed Breast Cancer: Room for Improvement

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2221-2223

2017

Volltextzugriff (PDF)

Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy

Journal of the American College of Surgeons, 2008-10, Vol.207 (4), p.543-548

2008

Volltextzugriff (PDF)

Reply to A. Gomberawalla et al and J. Nudelman

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3110-3111

2016

Volltextzugriff (PDF)

Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche

Breast disease, 2007-04, Vol.26 (1), p.65-74

2007

Volltextzugriff (PDF)

Evaluation of surgically excised breast tissue microstructure using wide‐field optical coherence tomography

The breast journal, 2020-05, Vol.26 (5), p.917-923

2020

Volltextzugriff (PDF)

Decision-Making in Breast Cancer Surgery: Where Do Patients Go for Information?

The American surgeon, 2016-05, Vol.82 (5), p.397-402

2016

Volltextzugriff (PDF)

Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery

Annals of surgical oncology, 2016-12, Vol.23 (13), p.4270-4276

2016

Volltextzugriff (PDF)

Breast Pathology Review: Does It Make a Difference?

Annals of surgical oncology, 2014-10, Vol.21 (11), p.3504-3508

2014

Volltextzugriff (PDF)

Clinicopathologic predictors of MRI utilization in newly diagnosed breast cancer patients

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.e50-e50

2015

Volltextzugriff (PDF)

Does the Benefit of Sentinel Node Frozen Section Vary Between Patients With Invasive Duct, Invasive Lobular, and Favorable Histologic Subtypes of Breast Cancer?

Annals of surgery, 2008, Vol.247 (1), p.143-149

2008

Volltextzugriff (PDF)

Abstract P3-06-14: Inhibition of PRKCQ enhances chemosensitivity of triple negative breast cancer by regulating EMT and Bim

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-06-14

2020

Volltextzugriff (PDF)

Post mastectomy reconstruction choice: Do race and ethnicity play a role?

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.1586-1586

2024

Volltextzugriff (PDF)

Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes

Annals of surgical oncology, 2009-07, Vol.16 (7), p.1952-1958

2009

Volltextzugriff (PDF)

Kaplan et al. reply

Nature (London), 2009-09, Vol.461 (7262), p.E5-E5

2009

Volltextzugriff (PDF)

From the Guest Editors

The cancer journal (Sudbury, Mass.), 2008-07, Vol.14 (4), p.214-215

2008

Volltextzugriff (PDF)

Prospective serial sequencing of CTC/cfDNA and NK cell activity in patients undergoing multimodality treatment for triple negative breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24108-e24108

2018

Volltextzugriff (PDF)

Don't give up your gamma probe

Annals of surgical oncology, 2004-09, Vol.11 (9), p.813-814

2004

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Lymphedema Precautions: Time to Abandon Old Practices?

Surgery No More? Managing the Primary Tumor in Stage IV Breast Cancer

HER-2/neu status is a determinant of mammary aromatase activity in vivo : Evidence for a cyclooxygenase-2-dependent mechanism

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Genetic Testing in Patients With Newly Diagnosed Breast Cancer: Room for Improvement

Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy

Reply to A. Gomberawalla et al and J. Nudelman

Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche

Evaluation of surgically excised breast tissue microstructure using wide‐field optical coherence tomography

Decision-Making in Breast Cancer Surgery: Where Do Patients Go for Information?

Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery

Breast Pathology Review: Does It Make a Difference?

Clinicopathologic predictors of MRI utilization in newly diagnosed breast cancer patients

Does the Benefit of Sentinel Node Frozen Section Vary Between Patients With Invasive Duct, Invasive Lobular, and Favorable Histologic Subtypes of Breast Cancer?

Abstract P3-06-14: Inhibition of PRKCQ enhances chemosensitivity of triple negative breast cancer by regulating EMT and Bim

Post mastectomy reconstruction choice: Do race and ethnicity play a role?

Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes

Kaplan et al. reply

From the Guest Editors

Prospective serial sequencing of CTC/cfDNA and NK cell activity in patients undergoing multimodality treatment for triple negative breast cancer

Don't give up your gamma probe

Suchergebnisse filtern